Chinook Therapeutics Inc

NASDAQ:KDNY  
15.44
-0.98 (-5.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Chinook Therapeutics Inc Stock, NASDAQ:KDNY

400 Fairview Avenue North, Suite 900, Seattle, Washington 98109
United States of America
Phone: +1.206.485.7051
Number of Employees: 105

Description

Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.